Auxly Cannabis Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Auxly Cannabis Group.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	54.4%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Recent updates

Investors Still Aren't Entirely Convinced By Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Despite 43% Price Jump

Nov 03

Is Auxly Cannabis Group (TSE:XLY) A Risky Investment?

Oct 02

Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story

Aug 09

Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower

Jun 19

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Apr 27

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Mar 21

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Feb 03

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Dec 19

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

Aug 11

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

Jul 21

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Aug 18

Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 29

Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)

Mar 24

A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns

Jan 28

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Auxly Cannabis Group yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

TSX:XLY - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CAD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	110	-45	9	11	N/A
3/31/2024	102	-60	1	3	N/A
12/31/2023	101	-45	7	8	N/A
9/30/2023	99	-7	0	6	N/A
6/30/2023	90	-99	-8	1	N/A
3/31/2023	96	-101	-1	8	N/A
12/31/2022	94	-130	-12	-2	N/A
9/30/2022	99	-133	-21	-22	N/A
6/30/2022	104	-86	-23	-26	N/A
3/31/2022	97	-75	-38	-38	N/A
12/31/2021	84	-46	-50	-50	N/A
9/30/2021	73	-53	-51	-44	N/A
6/30/2021	61	-57	-57	-43	N/A
3/31/2021	46	-81	-53	-39	N/A
12/31/2020	47	-84	-54	-33	N/A
9/30/2020	32	-116	-82	-52	N/A
6/30/2020	21	-115	-93	-59	N/A
3/31/2020	17	-102	-109	-73	N/A
12/31/2019	8	-103	-113	-79	N/A
9/30/2019	5	-80	-89	-71	N/A
6/30/2019	4	-72	-87	-66	N/A
3/31/2019	1	-70	-78	-55	N/A
12/31/2018	1	-67	-61	-44	N/A
9/30/2018	2	-41	-42	-29	N/A
6/30/2018	2	-38	-33	-25	N/A
3/31/2018	3	-27	N/A	-18	N/A
12/31/2017	2	-18	N/A	-11	N/A
9/30/2017	0	-9	N/A	-9	N/A
6/30/2017	0	-3	N/A	-3	N/A
3/31/2017	0	-2	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
9/30/2016	0	0	N/A	0	N/A
6/30/2016	0	0	N/A	0	N/A
3/31/2016	0	0	N/A	0	N/A
12/31/2015	0	0	N/A	0	N/A
9/30/2015	0	0	N/A	0	N/A
6/30/2015	0	0	N/A	0	N/A
3/31/2015	0	0	N/A	0	N/A
12/31/2014	0	0	N/A	0	N/A
9/30/2014	0	0	N/A	0	N/A
6/30/2014	0	0	N/A	0	N/A
3/31/2014	0	0	N/A	0	N/A
12/31/2013	0	0	N/A	0	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if XLY's forecast earnings growth is above the savings rate (2.2%).

Kazançlar ve Piyasa: Insufficient data to determine if XLY's earnings are forecast to grow faster than the Canadian market

Yüksek Büyüme Kazançları: Insufficient data to determine if XLY's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if XLY's revenue is forecast to grow faster than the Canadian market.

Yüksek Büyüme Geliri: Insufficient data to determine if XLY's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if XLY's Return on Equity is forecast to be high in 3 years time

Auxly Cannabis Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates fall by 47%

Consensus revenue estimates fall by 11%

Consensus EPS estimates fall by 12%

Consensus revenue estimates fall by 15%

Price target decreased to CA$0.41

Price target increased to CA$0.55

Recent updates

Investors Still Aren't Entirely Convinced By Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Despite 43% Price Jump

Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024

Is Auxly Cannabis Group (TSE:XLY) A Risky Investment?

Second quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.013 loss in 2Q 2023)

Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story

Auxly Cannabis Group Inc. to Report Q2, 2024 Results on Aug 15, 2024

Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower

First quarter 2024 earnings released: CA$0.026 loss per share (vs CA$0.011 loss in 1Q 2023)

Auxly Cannabis Group Inc. to Report Q1, 2024 Results on May 13, 2024

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings released: CA$0.045 loss per share (vs CA$0.15 loss in FY 2022)

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Auxly Cannabis Group Inc. to Report Q4, 2023 Results on Mar 25, 2024

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Third quarter 2023 earnings released: EPS: CA$0.033 (vs CA$0.067 loss in 3Q 2022)

Auxly Cannabis Group Inc. to Report Q3, 2023 Results on Nov 13, 2023

Insufficient new directors

New major risk - Market cap size

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

New major risk - Financial position

Second quarter 2023 earnings released: CA$0.013 loss per share (vs CA$0.016 loss in 2Q 2022)

Auxly Cannabis Group Inc. to Report Q2, 2023 Results on Aug 14, 2023

Auxly Cannabis Group Inc. Announces Executive Changes

Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?

First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.047 loss in 1Q 2022)

Auxly Cannabis Group Inc. to Report Q1, 2023 Results on May 15, 2023

Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks

Full year 2022 earnings released: CA$0.15 loss per share (vs CA$0.059 loss in FY 2021)

Auxly Cannabis Group Inc. announced that it has received CAD 3.36 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 3.36 million in funding

Morganti & Co. Issues Auxly Cannabis Group, Inc. Shareholder Class Action Notice of Certification

Consensus EPS estimates fall by 47%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Auxly Cannabis Group Inc. to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

An unknown buyer acquired Outdoor cultivation facility located in Hortonville, Nova Scotia from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 4.1 million.

Consensus revenue estimates fall by 11%

Auxly Cannabis Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Auxly Cannabis Group Inc. Introduces Edi's by Foray with the Launch of Large-Pack, Snackable Edibles

Consensus EPS estimates fall by 12%

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

An unknown buyer acquired Auxly Annapolis Inc from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 6 million.

Consensus revenue estimates fall by 15%

Auxly Cannabis Group Inc. Reports Impairment Changes for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Auxly Cannabis Group Inc. to Report Q1, 2022 Results on May 16, 2022

Price target decreased to CA$0.41

Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2022

Auxly Cannabis Group Inc. Announces Close of Robinsons Cultivation Facilities

KSM Securities Litigation Group Announces Ontario Court Grants Leave to Shareholders to Advance Statutory Claim Against Auxly Cannabis Securities Class Action

Price target increased to CA$0.55

Forecast to breakeven in 2024

Auxly Cannabis Group Inc. (TSX:XLY) acquired Sunens Farms Inc. from Peter Quiring for CAD 5 million.

Price target decreased to CA$0.51

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.028 loss in 3Q 2020)

Price target increased to CA$0.50

Second quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.046 loss in 2Q 2020)

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Consensus forecasts updated

Auxly Cannabis Group Inc. on Hot Streak Heading into Summer Packed with New Products

Auxly Cannabis Group Inc. has completed a Composite Units Offering in the amount of CAD 15.0003 million.

CEO & Director recently bought CA$169k worth of stock

Consensus EPS estimates fall to -CA$0.05

Myconic Capital Corp. (DB:MY0) completed the acquisition of KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY).

Price target decreased to CA$0.52